AG Leiter: Assoc. Prof. PD Dr. Martin Bodingbauer
AG Leiter: Medizinische Universität Wien
Universitätsklinik für Chirurgie
Währinger Gürtel 18-20
1090 Wien
Tel: +43-1-40400-56210
Fax: +43-1-40400-56410
Email: martin.bodingbauer@meduniwien.ac.at
Stellvertreter:
OA Dr. Helwig Wundsam
helwig.wundsam@Âordensklinikum.at
Aktuelles aus der Arbeitsgruppe
Literaturhinweise
20. 05.2019- Evaluation of the utility of prognostic models for patients with resected hilar cholangiocarcinoma.
- ASO Author Reflections: Understanding Recurrence Patterns and Time Courses of Intrahepatic Cholangiocarcinoma After Surgery Helps in Postoperative Surveillance and Treatment.
- Hepatocellular carcinoma: killing one bird with two stones.
- Validation of combination treatment with surgical spacer placement and subsequent particle radiotherapy for unresectable hepatocellular carcinoma.
- Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection.
- The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter?
- Macrophages in Colorectal Cancer Liver Metastases.
- Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.
- Conventional Chemoembolization Plus Radiofrequency Ablation versus Surgical Resection for Single, Medium-Sized Hepatocellular Carcinoma: Propensity-Score Matching Analysis.
- Surgical resection of neuroendocrine tumor liver metastases as part of multimodal treatment strategies: A propensity score matching analysis.
Literaturhinweise
2. 05.2019- Antimicrobial prophylaxis for 1 day versus 3 days in liver cancer surgery: a randomized controlled non-inferiority trial.
- Risk factors and prognosis of patients with recurrent hepatocellular carcinoma who undergo liver re-resections.
- Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment?
- Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
- Hepatocellular carcinoma in the noncirrhotic liver: a literature review.
- Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer.
- Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension.
- A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for liver metastases from colorectal cancer.
- Efficacy and safety of radiofrequency ablation versus minimally invasive liver surgery for small hepatocellular carcinoma: a systematic review and meta-analysis.
- Improved outcomes with surgery compared to radiofrequency ablation in the treatment of resectable hepatocellular carcinoma.
- Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection.
- Does the site of primary colorectal cancer influence the outcome after resection of isolated liver metastases?
- Treatment options for PNET liver metastases: a systematic review.
Literaturhinweise
17. 04.2019- Defining enhanced recovery after resection of peri-hilar cholangiocarcinoma.
- Hepatocellular Carcinoma.
- Minimally invasive resection of posterosuperior liver tumors in the supine position using intra-abdominal trocars.
- Relevance of Preoperative Hyperbilirubinemia in Patients Undergoing Hepatobiliary Resection for Hilar Cholangiocarcinoma.